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Gap junction communication (GJC) mediated by connexins is critical for heart function. To
gain insight into the causal relationship of molecular mechanisms of disease pathology, it
is important to understand which mechanisms contribute to impairment of gap junctional
communication. Here, we present an update on the known modulators of connexins,
including various interaction partners, kinases, and signaling cascades. This gap junction
network (GJN) can serve as a blueprint for data mining approaches exploring the growing
number of publicly available data sets from experimental and clinical studies.
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GAP JUNCTION COMMUNICATION IN HEALTH AND
DISEASE
Gap junction communication (GJC) describes the electrical and
metabolic coupling of cells through specialized cell contacts
called gap junctions. In vertebrates, gap junctions are present
in most tissues having important roles in development, growth
regulation, tissue homeostasis, and communication. They assem-
ble from homo- or hetero-hexameric connexin hemichannels
encoded by 20 (rodents) or 21 (human) different genes (Söhl
et al., 2005). GJC has been studied in great detail for the last 50
years. These studies emphasized importantmolecular, biophysical
properties, and physiological roles of connexin channels. Other
studies revealed connexin structures down to atomic resolution
(Maeda et al., 2009; Grosely and Sorgen, 2013) and a multi-
tude of regulatory mechanisms controlling the entire life cycle
of these channels from transcription, post-translational modifi-
cation, to removal of gap junctions and degradation (Laird, 2006;
Johnstone et al., 2012a; Su et al., 2012; Thévenin et al., 2013).
More recent work demonstrated connexin hemichannel functions
under physiological conditions (Bruzzone et al., 2001; Anselmi
et al., 2008; Garré et al., 2010) and evidence for channel indepen-
dent function, e.g., in cell growth and death (Vinken et al., 2012)
or migration (Kameritsch et al., 2012). Mutations in connexins
were discovered in inherited human diseases like oculodentodig-
ital dysplasia (ODDD, Cx43, GJA1; Huang et al., 2013), X-linked
Charcot-Marie-Tooth disease (Cx32, GJB1; Scherer and Kleopa,
2012), Pelizaeus-Merzbacher-like disease or a milder spastic para-
plegia (Cx47; Kleopa et al., 2010), Vohwinkel syndrome as well
as Keratitis-Icthyosis-Deafness (KID) syndrome (Cx26, GJB2; Lee
and White, 2009; Xu and Nicholson, 2013), Erythrokeratodermia
variabilis (Cx31, GJB3; Cx30.3, GJB4), Clouston syndrome
(Cx30, GJB6) or secondary lymphedema following breast cancer
treatment (Cx47, GJC2; Finegold et al., 2012). Furthermore, tran-
scriptional and post-transcriptional alterations and dysfunctional
degradation by autophagy (Lichtenstein et al., 2011; Fong et al.,
2012) may represent indirect mechanisms causing impaired GJC.
Today, a causal relationship, e.g., in the context of seizures (Li
et al., 2001; Gajda et al., 2005; Samoilova et al., 2008), cerebral
ischemia (Contreras et al., 2004; Talhouk et al., 2008; Orellana
et al., 2010), autism (Fatemi et al., 2008), schizophrenia (Meyer
et al., 2002; Aleksic et al., 2007), and after trauma (Frantseva
et al., 2002) seems plausible. Thus, understanding the exact roles
of GJC in health and disease is a highly relevant and timely
objective in biomedical and preclinical research. Transcriptome
studies have started to provide valuable insight into the conse-
quences of altered connexin expression in animal models (Spray
and Iacobas, 2007; Iacobas et al., 2012, 2007a), exploring the
use of coordination analysis of gene expression as a strategy to
identify connexin related gene networks. The huge amount of
transcriptome data available in public databases, together with
more sophisticated data processing tools, suggest that inves-
tigating transcriptional changes within a physiologically rele-
vant “gap junction network” (GJN) will have wide application
potential.
MODULATION OF GAP JUNCTION COMMUNICATION
The major cardiac connexin proteins are Cx40 (GJA5), Cx43
(GJA1), and Cx45 (GJC1), having distinct expression patterns and
essential roles in propagation of action potentials, metabolic cou-
pling, tissue homeostasis and heart development (Lo, 2000; Nishii
et al., 2001; Rohr, 2004; Bernstein and Morley, 2006; Zacchigna
et al., 2009; Jansen et al., 2010). Given these important functions,
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it is not surprising that GJC has been associated with various heart
diseases (Jongsma and Wilders, 2000; Severs, 2001; Severs et al.,
2004, 2008; Tribulová et al., 2008; Rodríguez-Sinovas et al., 2012;
Verheule and Kaese, 2013). Here, we will focus on interacting
and modulating proteins, clustered in functional groups, forming
the basis for a draft GJN (Figure 1). A complete list of proteins,
isoforms, and putative interactions in the GJN can be found in
Table 1, a list of proven interactions in Table 2, while functional
evidence is presented below. We will not discuss the structurally
related, non-gap junction forming pannexins, or LRRC8 (Abascal
and Zardoya, 2012), although it is interesting to note that pannex-
ins release cardioprotectants during ischemic events in the heart
(Wang et al., 2009; Vessey et al., 2010, 2011; Rodríguez-Sinovas
et al., 2012).
CELL-CELL JUNCTIONAL AND SCAFFOLDING PROTEINS
A shared communality among connexins is the binding
to junctional, scaffolding and cytoskeletal/transport proteins.
Interactions between connexins and the tight junction proteins
ZO-1, ZO-2, and ZO-3 (TJP1, TJP2, TJP3) vary regarding differ-
ent connexin and ZO proteins (Giepmans and Moolenaar, 1998;
Toyofuku et al., 1998; Kausalya et al., 2001), regulating connexon
to gap junction transition (Rhett et al., 2011) and, as shown for
ZO-1, can be regulated by c-Src in cardiac myocytes (Toyofuku
et al., 2001). Increased interaction of ZO-1 with Cx43 plays a role
in Cx43 down-regulation and reduced Cx43 gap junction size in
congestive heart failure (Bruce et al., 2008). Cell adhesion proteins
like E-cadherin (CDH1) and α-catenin are co-localized in newly
formed gap junctions (Fujimoto et al., 1997), and E-cadherin
mediated cell–cell contacts were shown to increase GJC (Jongen
et al., 1991). p120ctn (CTNND1) (Xu et al., 2001) and β -catenin
(CTNNB1) (Ai et al., 2000) also co-localize with Cx43, and
Cx43 was further found to immunoprecipitate with β-catenin (Li
et al., 2009). N-cadherin (CDH2)/connexin interactions were also
reported (Li et al., 2009). CDH2 antibodies inhibit gap junction
formation (Meyer et al., 1992), and cardiac specific CDH2 knock-
out inmice causes reduced GJC and sudden death (Li et al., 2005).
Vinculin (VCL) interacts with connexins (Iacobas et al., 2007b),
and cardiac myocyte specific VCL knockout caused Cx43 disloca-
tion, dilated cardiomyopathy, and sudden death (Zemljic-Harpf
et al., 2007). VCL also binds directly to ZO-1, stabilizing gap
junctions in the heart (Zemljic-Harpf et al., 2014). The tight junc-
tion protein occludin (OCLN) was shown to interact with Cx32
(Kojima et al., 1999) and ZO-1 as well as ZO-2 (Furuse, 1994; Itoh
et al., 1999).
AGS8 (FNDC1) forms a scaffold for Gβγ subunits and Cx43
and elicits phosphorylation and subsequent internalization, an
effect involved in hypoxia-induced apoptosis in cardiomyocytes
(Sato et al., 2009). In the brain, the scaffolding proteins MUPP1
(MPDZ) and AF6 (MLLT4) interact with Cx36 (Li et al., 2012).
Membrane targeting, cellular migration and wound healing are
modulated by Cx43 and interaction with the multidomain scaf-
folding protein CASK (Márquez-Rosado et al., 2012). Further,
all three known human caveolins (CAV), a group of proteins
found in lipid rafts and the membrane, interact with Cx43
(Langlois et al., 2008; Liu et al., 2010), increasing GJC (shown for
CAV1 and CAV2). Drebrin (DBN1) interacts with Cx43 main-
taining Cx43-containing gap junctions in their functional state
(Butkevich et al., 2004), likely involving further interactions with
the cytoskeleton.
FIGURE 1 | Simplified summary of the gap junction network. This
cartoon summarizes important signaling pathways, modulators, and
interacting proteins of connexins, which converge exemplarily on a
(green) connexin gap junction channel. The major functional groups
outlined in the main text have been color-coded and relations between
groups indicated by arrows. Further, phosphorylation (P) and
dephosphorylation (-P) is highlighted. Note that the depicted
pathways/interactions will vary for individual connexins. The gap junction
network includes G proteins (light blue), cyclases (dark blue), kinases
(violet), MAPK/ERK related signaling pathways (orange), receptors (red),
scaffolding and junctional proteins (pink), cytoskeleton (dark pink), and
cell cycle associated proteins (yellow).
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Table 1 | A draft of a gap junction network gene list.
ADCY1, ADCY10, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9, AQP1, AQP2, AQP3, AQP4, AQP5, AQP6, AQP7, AQP8, AQP9,
AQP10, AQP11, AQP12A, AQP12B, BAX, CALM1, CALM2, CALM3, CAMK1, CAMK1D, CAMK1G, CAMK2A, CAMK2B, CAMK2D, CAMK2G, CAMK4,
CASK, CAV1, CAV2, CAV3, CCNE1, CDC2, CDH1, CDH10, CDH11, CDH12, CDH13, CDH14, CDH15, CDH16, CDH17, CDH18, CDH19, CDH2, CDH20,
CDH3, CDH4, CDH5, CDH6, CDH7, CDH8, CDH9, CIP85, CSNK1A1, CSNK1A1L, CSNK1D, CSNK1G1, CSNK1G2, CSNK1G3, CSNK2A1, CSNK2A2,
CSNK2B, CTNNA1, CTNNA2, CTNNA3, CTNNAL1, CTNNB1, CTNNBL1, CTNND1, CTNND2, DBN1, EGFR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8,
GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, GNA11, GNA12, GNA13, GNA14, GNA15,
GNAI1, GNAI2, GNAI3, GNAL, GNAO1, GNAQ, GNAS, GNAT1, GNAT2, GNAT3, GNAZ, GNB1, GNB1L, GNB2, GNB2L1, GNB3, GNB4, GNB5,
GNG10, GNG11, GNG12, GNG13, GNG2, GNG3, GNG4, GNG5, GNG7, GNG8, GNGT1, GNGT2, GRB2, GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3,
GUCY2A, GUCY2B, GUCY2C, GUCY2E, HRAS, HSP70-1A, HSP70RY, HSP70-4, HSP70-1B, HSP70T, HSP70-3, KRAS, MAP2K1, MAP2K2, MAP2K3,
MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K1, MAP3K10, MAP3K11, MAP3K12, MAP3K13, MAP3K14, MAP3K15, MAP3K2, MAP3K3, MAP3K4,
MAP3K5, MAP3K6, MAP3K7, MAP3K8, MAP3K9, MAP4K1, MAP4K2, MAP4K3, MAP4K4, MAP4K5, MAPK1, MAPK10, MAPK11, MAPK12, MAPK13,
MAPK14, MAPK15, MAPK3, MAPK4, MAPK6, MAPK7, MAPK8, MAPK9, MLLT4, MPDZ, NRAS, OCLN, P2-receptor, P2RX7, P2RY1, PANX1, PANX2,
PANX3, PDGFRA, PDGFRB, PDGFRL, PKP1, PKP2, PKP3, PKP4, PLCB1, PLCB2, PLCB3, PLCB4, PLCD1, PLCD3, PLCD4, PLCE1, PLCG1, PLCG2,
PLCH1, PLCH2, PLCL1, PLCL2, PLCZ1, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKACA, PRKACB, PRKACG, PRKAG1, PRKAG2, PRKAG3, PRKAR1A,
PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB, PRKCD, PRKCDBP, PRKCE, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PRKG1, PRKG2, PTPRM,
RAF1, SOS1, SOS2, SRC, TJAP1, TJP1, TJP2, TJP3, TSG101, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBA8, TUBAL3,
TUBB1, TUBB2A, TUBB2C, TUBB3, TUBB4, TUBB6, TUBD1, TUBE1, TUBG1, TUBG2, VCL
Summarizing GJC/connexin interaction/modulating proteins, we propose a draft of a GJN forming the blueprint to investigate the role of GJC. Known GJCmodulators,
as well as putative ones (isoforms and other closely related proteins) are included, with the intent to foster research on GJN modulation in health and disease.
CYTOSKELETON
Connexins are known to directly interact with α-and β-tubulin
(Giepmans et al., 2001a,b). There are multiple different tubu-
lin subunits and regional differences in their expression may be
linked to schizophrenia (Moehle et al., 2012). Direct interactions
of connexins with actin were not reported, but connexins co-
localize with actin, which was linked to anterograde Cx43 traf-
ficking (Wall et al., 2007; Smyth et al., 2012). Interactions
with actin can be mediated via various scaffolding proteins
including drebrin (Butkevich et al., 2004; Majoul et al., 2007)
and ZO-1 (Rhett et al., 2011). Further, Cx43 interacts with
plakophilin-2 (PKP2) (Li et al., 2009; Sato et al., 2011), a
protein linking cadherins to intermediate filaments in the
cytoskeleton. Finally, expression of six cytoskeletal proteins (actin,
tropomyosin, microtubule-associated protein RP/EB1, transgelin,
GFAP, cofilin-1) were differentially regulated when Cx43 expres-
sion was targeted in astrocytes with small interfering (si)RNAs
(Olk et al., 2010).
KINASES
Phosphorylation of connexins has various effects on GJC and
plays major roles at several steps of the connexin lifecycle, includ-
ing trafficking, assembly/disassembly, degradation, and gating
(Lampe and Lau, 2004). PKA can phosphorylate connexins and
promote their synthesis and assembly/stability (Imanaga et al.,
2004; Ouyang et al., 2005; Zhang et al., 2005; Urschel et al.,
2006; Liu et al., 2011a). PKCs (PRKC) modulate Cx43, including
direct phosphorylation through PKCε (PRKCE), and increased
phosphorylation mediated by PKCα (PRKCA) (Bowling et al.,
2001). Further, PKCδ (PRKCD)was shown to bind to Cx43 (Niger
et al., 2010). PKCs are considered a therapeutic target due to
the expression of multiple PKCs in the heart and their expres-
sion changes and contribution to heart diseases (Liu et al., 2009;
Palaniyandi et al., 2009). The cGMP dependent Protein kinase
G (cGK, PKG, PRKG) was also reported to phosphorylate con-
nexins and modulate their expression (Kwak et al., 1995; Patel
et al., 2006; Joshi et al., 2012). Mammals inherit two PRKGs, cGKI
(PRKG1), and cGKII (PRKG2), where PRKG1 is the main PRK in
the heart. PRKG1 has well-known functions in the cardiovascular
system, including excitation-contraction coupling, contractility,
CM hypertrophic remodeling and more, where elevated cGMP
levels protect against adverse ventricular remodeling (Balligand
and Hammond, 2013; Frantz et al., 2013). In the failing human
heart, PKA, as well as PKC and PKG, can phosphorylate car-
diac ryanodine receptors, resulting in defective channel function
due to increased sensitivity (Takasago et al., 1991; Marx et al.,
2000). Ca2+/calmodulin-dependent protein kinase II (CaMKII)
can phosphorylate Cx43, and its activation and/or increased
expression occurs in cardiac disease states like infarction, hyper-
trophy, and myocardial ischemia (see Erickson and Anderson,
2008; Huang et al., 2011 and references within) and is there-
fore considered a drug target in heart failure (Bers, 2010). The δ
(CAMK2D) subunit is the highest expressed CaMKII in the heart,
besides the γ (CAMK2G) subunit being expressed at lower levels
(Schworer et al., 1993; Edman and Schulman, 1994). Calmodulin
(CaM) activates CaMKII, and also directly modulates connexin
gating properties andmediating Ca2+-induced uncoupling of gap
junctions (review: Zou et al., 2014). Connexins can be modulated
by casein kinase 1 (CK1) and CK2 (Cheng and Louis, 1999; Yin,
2000). Besides the finding that CK1δ (CSNK1D) regulates Cx43
gap junction assembly (Cooper and Lampe, 2002), little is known
about which CKs targets for other connexins. CK2α1 dependent
phosphorylation may be involved in the development of cardiac
hypertrophy (Eom et al., 2011).
MAP KINASE SIGNALING CASCADES
The mitogen-activated protein kinase (MAPK) cascades are key
intracellular signaling pathways regulating diverse cellular func-
tions such as proliferation, differentiation, survival, development,
stress response, and apoptosis. Multiple MAPK cascades have
been identified, and although often described as linear, they
display significant cross talk (Keshet and Seger, 2010). In the
heart, H-Ras, K-Ras, and N-Ras are expressed (Potenza et al.,
2005). MAPKs have functions in heart development and are also
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Table 2 | Summary of connexin interacting proteins.
Interacting protein Connexin Type of detection References
CELL–CELL JUNCTIONAL AND SCAFFOLDING PROTEINS
α-catenin GJ co-loc, EM, FRIL Fujimoto et al., 1997
β-catenin Cx43 co-loc in cardiac myocytes, β-catenin-IP (N) Ai et al., 2000; Lee and White, 2009
actin Cx43 co-loc Wall et al., 2007; Smyth et al., 2012
AF6 Cx36 AF6-IP (N), Cx36-IP (N), co-loc Li et al., 2012
AGS8 Cx43 IVB, co-loc Sato et al., 2009
CASK Cx36 IVB, co-loc, Far-WB, CASK-IP (N, RE) Márquez-Rosado et al., 2012
CAV1 Cx43 CAV1-IP (RE), co-loc, IVB Langlois et al., 2008
CAV2 Cx43 CAV2-IP (RE), co-loc, IVB Langlois et al., 2008
CAV3 Cx43 CAV3-IP (N), co-loc, IVB Liu et al., 2010
CDH1 GJ co-loc, EM, FRIL Fujimoto et al., 1997
CDH2 Cx43 N-cadherin-IP (N), co-loc Lee and White, 2009
drebrin Cx43 co-loc, IVB Butkevich et al., 2004
MUPP1 Cx36 Cx36-IP (N), MUPP1-IP (N), co-loc Li et al., 2012
occludin Cx43 occludin-IP (RE), co-loc Kojima et al., 1999
p120ctn Cx43 co-loc Xu et al., 2001
PKP2 Cx43 PKP2-IP (N) Lee and White, 2009; Sato et al., 2011
tubulin Cx43 co-loc, IVB Giepmans et al., 2001a,b
vinculin Cx43 AB-array, Cx43-IP (N) Iacobas et al., 2007a,b
ZO-1 Cx43 co-loc cardiac myocytes, ZO1-IP (RE, N), Cx43-IP (RE), IVB Giepmans and Moolenaar, 1998; Toyofuku et al.,
1998
Cx45 ZO-1-IP (RE), co-loc, Y2H (PDZ Domain), IVB Kausalya et al., 2001
ZO-2 Cx43 IVB, ZO2-IP (N), Cx43-IP (N), co-loc, Far-WB Singh et al., 2005
ZO-3 Cx45 Y2H (PDZ domains) Kausalya et al., 2001
KINASES
PKA Cx35 IVP Ouyang et al., 2005
Cx36 IVP Urschel et al., 2006
Cx50 IVP, in vivo phosphorylation, Liu et al., 2011a,b
PKC Cx43 PKCα-IP (N), Cx43-IP (N; PKCα, PKCε, PKCδ), Bowling et al., 2001; Niger et al., 2010
co-loc (PKCα, PKCε, PKCδ), IVP (PKCδ), PKCδ-IP
PKG Cx35 IVP Patel et al., 2006
PKG Cx43 IVP Kwak et al., 1995; Patel et al., 2006
CaMKII Cx43 IVP, co-loc Hund et al., 2008; Huang et al., 2011
calmodulin Cx32 co-loc Peracchia et al., 2000
CKI Cx49 IVP Cheng and Louis, 1999
Cx43 IVP, Cx43-IP (N) Cooper and Lampe, 2002
CKII Cx45.6(av) IVP, in vivo phosphorylation Yin, 2000
MAPK7/ERK5 Cx43 IVP, ERK5-IP (RE), Cx43-IP (RE) Cameron et al., 2003
c-Src Cx43 Cx43-IP (N, RE) Toyofuku et al., 2001; Li et al., 2009
CIP85 Cx43 Co-loc, CIP85-IP (RE, N) Lan et al., 2005
RECEPTORS
RPTPμ Cx43 RPTPμ-IP (RE), Cx43-IP (N, RE) Giepmans et al., 2003
AQP0 Cx45.6(av) Cx45.6-IP (N), co-loc Yu and Jiang, 2004; Yu et al., 2005
Cx56(av) Cx56-IP (N) Yu and Jiang, 2004
P2X7 Cx43 Cx43-IP (N), P2X7 (N), co-loc, AB-array, Fortes et al., 2004; Iacobas et al., 2007a,b
CELL CYCLE/CELL DEATH
cyclin E Cx43 co-loc, Cx43-IP (N), cyclin E-IP (N) Johnstone et al., 2012a,b
HSP70 Cx43 co-loc, Cx43-IP (N) Hatakeyama et al., 2013
TGS101 Cx43 Y2H, TGS101-IP (N), co-loc Auth et al., 2009
Cx36 Y2H, TGS101-IP (N) Auth et al., 2009
Cx30.2 Y2H Auth et al., 2009
BAX Cx43 Cx43-IP (RE) Sun et al., 2012
Summary of connexin interacting proteins. This table summarizes documented interactions described in the text and the detection methods used. It does not
include indirect interactions with regulatory pathways. Abbreviations in alphabetic order: AB-array, antibody array; av, avian connexin; co-loc, co-localization in cells
or tissues; IVB, in vitro binding, binding of peptides or functional domains; Far-WB, Far western blot; IVP, in vitro phosphorylation; N, native, non-transfected tissues,
cells, or cell lines; RE, one or both IP partners were expressed in recombinant cells; Y2H, yeast two hybrid assay.
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involved in heart disease formation (Rose et al., 2010). MAPK
phosphorylation of connexins is well-documented (reviews:
Giepmans, 2004; Solan and Lampe, 2005), e.g., MAPK7/ERK5
was reported to phosphorylate and associate with Cx43, reg-
ulating gap junction uncoupling (Cameron et al., 2003). The
non-receptor protein tyrosine kinase protein c-Src inhibits the
interaction of Cx43 and ZO-1 in cardiac myocytes (Toyofuku
et al., 2001). Further, c-Src activation was shown to inhibit gap
junctional coupling and remodeling in ischemic heart disease
(review: Giepmans, 2004; Rutledge et al., 2012). A Rab-GAP-like
protein, CIP85, interacts with Cx43 and induce its internalization
and degradation (Lan et al., 2005; Cochrane et al., 2013).
HETEROTRIMERIC G-PROTEINS
G proteins can interact with GJC by their activation/inhibition
of different signaling cascades, e.g., via adenylyl cyclase or
phospholipase C (see below). General consent is that GNAI2 is
the main Giα in the heart, GNAI3 is expressed in lower amounts
and GNAI1 is not expressed (Eschenhagen et al., 1992). However,
there are few studies investigating expression of GNAI1 in
detail. One newer study reports some cardiac GNAI1 expression
(Dizayee et al., 2011) in the heart, alongside the knowledge
of its expression in erythrocytes (Olearczyk et al., 2004) and
thrombocytes (Patel et al., 2003). GNAI2 is thought to be
up-regulated in various heart diseases, but maybe not in ischemic
heart disease (ICM) (Feldman et al., 1988; Neumann et al., 1988;
Böhm et al., 1990; Eschenhagen et al., 1992). Lack of Gαo leads
to tachycardia and defects in short-term heart rate dynamics
(Zuberi et al., 2008). Goand Gi may be involved in gap junction
assembly, as pertussis toxin (PTX) sensitive G proteins were
linked to Cx43 trafficking (Lampe et al., 2001). Overexpression
of Gs(GNAS) causes many features of dilated cardiomyopathy
(DCM) (Iwase et al., 1997), and haplotypes causing different
expression levels of Gshave been found in humans (Frey et al.,
2009), providing a putative link to heart disease risk. Gq (GNAQ)
overexpression leads to heart hypertrophy and contractile failure
in transgenic mice (D’Angelo et al., 1997; Fan et al., 2005),
and knockout prevents ventricular hypertrophy in response to
pressure-overload (Wettschureck et al., 2001). Gα13 regulates the
expression of hypertrophic and fibrotic genes in cardiomyocytes,
and inactivation prevents cardiac decompensation (Finn, 1999;
Takefuji et al., 2012).
CYCLASES AND PHOSPHOLIPASE C
Modulators of the soluble guanylate cyclase (sGC, GUCY) are
promising new drugs for heart failure treatment (Mitrovic et al.,
2011). sGC is a heterodimer composed of one α (GUCYA), and
one heme-binding β domain (GUCYB), of which sGCα1β1 is
the principal heteromer in the heart (see Mitrovic et al., 2011
and references within). Adenylyl cyclase type III (ADCY) is con-
sidered a therapeutic target for heart diseases, where from 10
known ADCYs ADCY5 and ADCY6 are the predominant ones
in the heart, expressed in a development-dependent way (e.g.,
Feldman, 2002 and references within), but several others are also
expressed (Ludwig and Seuwen, 2002). Phospholipase C (PLC)
cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into DAG
and inositol 1,4,5-trisphosphate (IP3). DAG remains bound to
the membrane, and IP3 is released as a soluble structure into the
cytosol activating IP3 calcium channels in the smooth endoplas-
mic reticulum. In addition, calcium and DAG activate PKC. A
majority of the 15 known PLCs is present in the heart and some
were linked to heart dysfunction (Schwertz and Halverson, 1992;
Meij et al., 1997; Hwang et al., 2004; Mangat et al., 2006; Ichise
et al., 2009; Otaegui et al., 2010). PLCβ3 was reported to co-
localize with Cx43, via the scaffolding protein ZO-1 (see below),
where localized changes in PIP2 levels dictate channel inhibition
(Van Zeijl et al., 2007).
RECEPTORS
Connexins interact with various other membrane proteins. The
receptor protein tyrosine phosphatase (PTP) family regulates a
variety of cellular processes including cell growth, differentia-
tion, and mitotic cycle. RPTPμ (PTPRM) can bind and possibly
dephosphorylate Cx43, counteracting c-Src phosphorylation, and
preventing channel closure (Giepmans et al., 2003). The epider-
mal growth factor receptor (EGFR) is a receptor tyrosine kinase
of the ErbB family. EGFR activation led to connexin phosphoryla-
tion and increased cytosolic localization of Cx43 possibly via the
PI3/Akt signaling pathway (Díez et al., 1998; Abdelmohsen et al.,
2003; Dubé et al., 2012). Platelet-derived growth factor receptors
(PDGFRs) are receptors with intracellular tyrosine kinase activity,
initiating intracellular signaling through the MAPK, PI3K, and
PKCγ pathways. PDGFR activation was shown to lead to Cx43
phosphorylation by MAPK signaling (Hossain et al., 1999a,b,
1998a,b; Shen et al., 2013). PDGFRs have a vital role to load-
induced cardiac stress response, angiogenesis, and regeneration
(Schatteman et al., 1995; Van den Akker et al., 2008; Bleyl et al.,
2010; Chintalgattu et al., 2010; Kim et al., 2010; Chong et al.,
2013). The cystic fibrosis transmembrane conductance regulator
(CFTR) regulates GJC possibly via a complex mechanism involv-
ing c-Src, modulating voltage sensitivity and gating. Further,
functional interaction of gap junctions, CFTR and glutamate
receptors (GluRs) were reported, although the molecular mecha-
nism is unclear (review: Chanson et al., 2007). GluRs were found
in the human myocardium, conducting system, nerve fibers,
and intramural ganglia cells (Gill et al., 2007), and glutamate
changes intracellular calcium oscillations in cultured rat myocar-
dial cells (Winter and Baker, 1995). Together, GluRs are likely to
play a physiological role in heart functions including contraction
and rhythm, although their precise role is still elusive. Various
aquaporins (AQP) are expressed in the heart, and although the
information available is still limited, they were reported to medi-
ate water flux across endothelial membranes, modulate calcium
signaling, and nutrient delivery to the heart (Rutkovskiy et al.,
2013). AQP0 was shown to interact with gap junctions and in
particular with Cx50 in differentiating lens fibers (Yu and Jiang,
2004), enhancing gap junctional coupling (Liu et al., 2011b), sug-
gesting a putative role for AQP/connexin interactions in the heart.
Finally, interactions between connexins and purinergic receptors
provide an interesting link of connexins to ATP signaling (Fortes
et al., 2004; Iacobas et al., 2007b).
CELL CYCLE/CELL DEATH
Beyond interactions at the plasma membrane and cytosol,
connexins can interact with proteins shuttling between cytoplasm
and nucleus, or proteins located in mitochondria. Cx43 interacts
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with cyclin E (CCNE1), for example after MAPK phosphory-
lation, promoting smooth muscle cell proliferation (Johnstone
et al., 2012b). Cx43 also competes with cyclin D1 for bind-
ing to heat shock protein 70 (HSP70) (Hatakeyama et al.,
2013). Further, degradation of connexins was linked to bind-
ing to tumor susceptibility gene 101 (TSG101), an ubiquitin–
conjugating enzyme associated with the cell cycle, turnover
of proteins, and transcriptional regulation (Auth et al., 2009).
Cyclin-dependent kinase 2 (CDC2) was shown to phosphorylate
Cx43 in a cell-cycle dependent manner (Kanemitsu et al., 1998;
Lampe et al., 1998). Connexins also interact with BAX, a mem-
ber of the Bcl-2 protein family located in the outer mitochondrial
membrane, to regulate apoptosis (Sun et al., 2012).
FUTURE DIRECTIONS: TOWARD META-ANALYSIS OF THE
GAP JUNCTION NETWORK?
Experimental investigation of the GJN is challenging, due to
the large number of putative interactions, procedural issues
or the huge experimental variations caused by small sample
sizes frequently found in studies using human tissues. However,
meta-analyses can capitalize from the growing number of mul-
tiple microarray and other “–omics” studies publicly available.
Technically, different approaches to merge and perform a statisti-
cal analysis have been established and various software tools allow
users to process microarray data (Saeed et al., 2003; Gentleman
et al., 2004; Reich et al., 2006; Tseng et al., 2012; Xia et al., 2013).
Unfortunately, cross-comparison of studies is still a major chal-
lenge, but the recently developed online platform INMEX (Xia
et al., 2013), or a LabVIEW-based software tool called Array Data
Extractor (ADE) (Kurtenbach et al., 2013) are efforts towardmak-
ing microarray data available in a user-friendly way to a large
community. This opens the opportunity to test physiologically
relevant changes of the proposed GJN in health and disease.
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